Stamp A J, Dorman M L, Vernazza C R, Deeming G, Reid C, Wilson K E, Girdler N M
Queensway Dental Clinic, Billingham.
Centre for Oral Health Research, Newcastle University.
Br Dent J. 2017 Jan 27;222(2):113-119. doi: 10.1038/sj.bdj.2017.78.
Background Surgical dentistry during orthodontic care often occurs in adolescence and may involve surgical removal or exposure of teeth. The invasive nature of treatment, combined with dental anxiety, means care can often be provided under general anaesthesia (GA). Best-practice guidelines however endorse conscious sedation as an alternative, where appropriate. Although a limited number of studies have shown safe and effective use of intravenous conscious sedation (IVCS) with midazolam in this cohort, robust evidence to support routine use is lacking. Aim To assess whether IVCS with midazolam can effectively facilitate surgical dentistry in adolescent orthodontic patients in primary care.Method A retrospective service evaluation was undertaken reviewing clinical records of adolescents (aged 12-15 years) undergoing surgical exposure and/or surgical removal of teeth under IVCS with midazolam.Results A total of 174 adolescents (mean age 14.2 years) attended for treatment between 2009 and 2015. Of these adolescents, 98.9% (N = 172) allowed cannulation, with all surgical dentistry completed during a single visit. Midazolam dose ranged from 2-7 mg with 79.1% of patients having good or excellent cooperation and three minor adverse events occurring.Conclusion This service evaluation shows IVCS with midazolam can effectively facilitate surgical orthodontics in carefully selected adolescents. There is however a distinct need to further explore potential for this technique to provide a viable alternative to GA.
背景 在正畸治疗期间进行的外科牙科手术通常发生在青少年时期,可能涉及牙齿的外科拔除或暴露。治疗的侵入性加上牙科焦虑,意味着通常需要在全身麻醉(GA)下进行治疗。然而,最佳实践指南支持在适当情况下将清醒镇静作为一种替代方法。尽管有少数研究表明在该队列中使用咪达唑仑进行静脉清醒镇静(IVCS)是安全有效的,但缺乏支持常规使用的有力证据。
目的 评估使用咪达唑仑进行IVCS是否能有效促进初级保健中青少年正畸患者的外科牙科手术。
方法 进行了一项回顾性服务评估,回顾了在使用咪达唑仑进行IVCS的情况下接受牙齿外科暴露和/或外科拔除的青少年(12至15岁)的临床记录。
结果 在2009年至2015年期间,共有174名青少年(平均年龄14.2岁)接受治疗。在这些青少年中,98.9%(N = 172)允许插管,所有外科牙科手术均在单次就诊时完成。咪达唑仑剂量范围为2至7毫克,79.1%的患者配合良好或极佳,发生了3起轻微不良事件。
结论 这项服务评估表明,使用咪达唑仑进行IVCS可以有效促进精心挑选的青少年的外科正畸治疗。然而,迫切需要进一步探索该技术提供GA可行替代方案的潜力。